{"ModuleTitle": "Company Description", "CompanyName": "Supernus Pharmaceuticals, Inc.", "Symbol": "SUPN", "Address": "9715 KEY WEST AVENUE, ROCKVILLE, Maryland, 20850, United States of America", "Phone": "301-838-2500", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Supernus Pharmaceuticals, Inc. (the Company) was incorporated in Delaware, and\r\ncommenced operations in 2005. The Company became publicly traded in 2012 and is\r\nlisted on The NASDAQ Stock Exchange under the ticker symbol SUPN. Our principal\r\nexecutive offices are located in Rockville, Maryland.\r\nWe are a pharmaceutical company focused on developing and commercializing\r\nproducts for the treatment of central nervous system (CNS) diseases in neurology\r\nand psychiatry. Our extensive expertise in product development has been built\r\nover the past 25 years: initially as a privately-held stand-alone development\r\norganization; then, as a United States (U.S.) subsidiary of Shire Plc (Shire, a\r\nsubsidiary of Takeda Pharmaceutical Company Ltd.); and upon our acquisition of\r\nsubstantially all of the assets of Shire Laboratories Inc. in late 2005, as\r\nSupernus Pharmaceuticals.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f28%2f0001356576-20-000010.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Frank Mottola", "title": "Vice President-Quality & Information Technology"}, {"name": "Gregory S. Patrick", "title": "Chief Financial Officer & Senior Vice President"}, {"name": "Jack A. Khattar", "title": "President, CEO, Secretary & Director"}, {"name": "Padmanabh P. Bhatt", "title": "Chief Scientific Officer & Senior Vice President"}, {"name": "Stefan K. F. Schwabe", "title": "Chief Medical Officer, EVP-Research & Development"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}